IMC001 for Clinical Research on Advanced Digestive System Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Advanced Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
- Status
- COMPLETED
- Phase
- N/A
Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)
- Status
- COMPLETED
- Phase
- PHASE2
ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable or
- Status
- UNKNOWN
- Phase
- N/A
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT
- Status
- TERMINATED
- Phase
- PHASE3
Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Camrelizumab Utilization on Patients With Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- NA
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- PHASE1
Efficacy and Safety of IBI310 Combined with Sintilimab in Patients with Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Itacitinib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE1